Alberta Stroke Program Early CT Score (ASPECTS)
ورودیهای بالینی بیمار
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Extensive Infarction0–4
- Large Infarction5–7
- Favorable8–10
Clinical Decision Pathway
Clinical Decision Pathway & Next Steps
Stroke, TIA & Intracranial Hemorrhage — سکته مغزی، TIA و خونریزی داخل جمجمه
Clinical Rationale:
Risk-stratify TIA with ABCD2, quantify stroke severity with NIHSS, evaluate early CT changes with ASPECTS, measure hematoma volume with ABC/2 and mortality with ICH Score, then balance anticoagulation with CHA2DS2-VASc and HAS-BLED.
NIH Stroke Scale/Score (NIHSS)
مقیاس سکته NIH (NIHSS)
Recommended Clinical Next Steps:
ABC/2 Formula for Intracerebral Hemorrhage Volume
فرمول ABC/2 برای حجم خونریزی داخل مغزی
Why next: Parenchymal hematoma volume quantificationIntracerebral Hemorrhage (ICH) Score
امتیاز ICH (خونریزی داخل مغزی)
Why next: 30-day intracerebral hemorrhage mortalityCHA₂DS₂-VASc Score for Atrial Fibrillation Stroke Risk
امتیاز CHA₂DS₂-VASc (ریسک سکته در AF)
Why next: Stroke risk and anticoagulation indication in AF
The Alberta Stroke Program Early CT Score (ASPECTS) calculates quantifying neurological deficit severity, stroke volume, and reperfusion therapy eligibility. Key inputs include caudate. Scores guide initiating intravenous thrombolysis, activating endovascular thrombectomy pathways, or secondary prevention protocols. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
Quantifies early ischemic changes in MCA territory on non-contrast CT to predict stroke outcome and guide treatment decisions
Clinical Indication
The Alberta Stroke Program Early CT Score (ASPECTS) is indicated for bedside clinical practice to support Quantifies early ischemic changes in MCA territory on non-contrast CT to predict stroke outcome and guide treatment decisions. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients presenting with acute neurological deficits, acute ischemic stroke, intracranial hemorrhage, seizures, or altered mental status. Clinical application is indicated across Comprehensive stroke centers, acute neurovascular units, neuro-ICU, and emergency neurology services.
Limitations & Contraindications
Stroke mimics including severe hypoglycemia, Todd postictal paresis, and hemiplegic migraine must be ruled out prior to intravenous thrombolysis.
Clinical Pearls & Action Plan
Time is brain; rapid determination of Last Known Well time and baseline functional status dictates reperfusion eligibility.
Start with 10 points. Subtract 1 point for each region with focal edema or parenchymal hypoattenuation: Caudate, Lentiform, Internal Capsule, Insular ribbon, M1, M2, M3, M4, M5, M6
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| caudate | string | Yes | Caudate nucleus - focal edema or parenchymal hypoattenuation |
| lentiform | string | Yes | Lentiform nucleus - focal edema or parenchymal hypoattenuation |
| internal_capsule | string | Yes | Internal capsule - focal edema or parenchymal hypoattenuation |
| insular_ribbon | string | Yes | Insular ribbon/cortex - focal edema or parenchymal hypoattenuation |
| m1 | string | Yes | M1 - Anterior MCA cortex (frontal operculum) - focal edema or parenchymal hypoattenuation |
| m2 | string | Yes | M2 - MCA cortex lateral to insular ribbon (anterior temporal) - focal edema or parenchymal hypoattenuation |
| m3 | string | Yes | M3 - Posterior MCA cortex (posterior temporal) - focal edema or parenchymal hypoattenuation |
| m4 | string | Yes | M4 - Anterior MCA cortex superior to M1 - focal edema or parenchymal hypoattenuation |
| m5 | string | Yes | M5 - Lateral MCA cortex superior to M2 - focal edema or parenchymal hypoattenuation |
| m6 | string | Yes | M6 - Posterior MCA cortex superior to M3 - focal edema or parenchymal hypoattenuation |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–4 | Extensive Infarction | Extensive MCA territory involvement |
| 5–7 | Large Infarction | Large MCA territory involvement |
| 8–10 | Favorable | Limited MCA territory involvement |
Evidence-Based References (EBM)
- Barber PA, Demchuk AM, Zhang J, Buchan AM. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score. Lancet. 2000;355(9216):1670-4.
- Pexman JH, Barber PA, Hill MD, et al. Use of the Alberta Stroke Program Early CT Score (ASPECTS) for assessing CT scans in patients with acute stroke. AJNR Am J Neuroradiol. 2001;22(8):1534-42.
- Goyal M, Demchuk AM, Menon BK, et al. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med. 2015;372(11):1019-30.